EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:3636 - chloroprocaine
| Formula | C13H19ClN2O2 |
| Net Charge | 0 |
| Average Mass | 270.760 |
| Monoisotopic Mass | 270.11351 |
| SMILES | CCN(CC)CCOC(=O)c1ccc(N)cc1Cl |
| InChI | InChI=1S/C13H19ClN2O2/c1-3-16(4-2)7-8-18-13(17)11-6-5-10(15)9-12(11)14/h5-6,9H,3-4,7-8,15H2,1-2H3 |
| InChIKey | VDANGULDQQJODZ-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | local anaesthetic Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. central nervous system depressant A loosely defined group of drugs that tend to reduce the activity of the central nervous system. peripheral nervous system drug A drug that acts principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| chloroprocaine (CHEBI:3636) has functional parent 2-diethylaminoethanol (CHEBI:52153) |
| chloroprocaine (CHEBI:3636) has functional parent 4-amino-2-chlorobenzoic acid (CHEBI:59472) |
| chloroprocaine (CHEBI:3636) has role analgesic (CHEBI:35480) |
| chloroprocaine (CHEBI:3636) has role central nervous system depressant (CHEBI:35488) |
| chloroprocaine (CHEBI:3636) has role local anaesthetic (CHEBI:36333) |
| chloroprocaine (CHEBI:3636) has role ophthalmology drug (CHEBI:66981) |
| chloroprocaine (CHEBI:3636) has role peripheral nervous system drug (CHEBI:49110) |
| chloroprocaine (CHEBI:3636) is a benzoate ester (CHEBI:36054) |
| chloroprocaine (CHEBI:3636) is a monochlorobenzenes (CHEBI:83403) |
| Incoming Relation(s) |
| chloroprocaine hydrochloride (CHEBI:3637) has part chloroprocaine (CHEBI:3636) |
| IUPAC Name |
|---|
| 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate |
| INNs | Source |
|---|---|
| chloroprocaine | ChemIDplus |
| chloroprocainum | ChemIDplus |
| cloroprocaina | ChemIDplus |
| Synonyms | Source |
|---|---|
| 2-chloroprocaine | ChemIDplus |
| 4-amino-2-chlorobenzoic acid 2-(diethylamino)ethyl ester | ChEBI |
| chloroprocain | DrugBank |
| Chloroprocaine | KEGG COMPOUND |
| Citations |
|---|